Why you should attend
M&A activity continues to rebound nicely in 2011 on all fronts. Private equity transactions, tender offers and hostile bids are all on the increase. Among the unsolicited offers, some (Sanofi/Genzyme) ended well for bidders and others (Air Products/Airgas) not so well. Relatively reliable equity and debt markets have contributed to stabilizing the M&A landscape, and acquisition financing terms have continued their seemingly inexorable march back to pre-crisis standard. Activist shareholders are once again asserting influence, but at the same time several high profile votes went against the recommendations of the proxy advisory firms. Perhaps the most unsettling influence on the M&A field is the Delaware judiciary, which continues to produce dramatic and, at times, surprising opinions at a pace that stuns even the most seasoned practitioners. Join our expert faculty of lawyers, general counsels, regulators and investment bankers as we explore the fascinating state of M&A and the trends you need to be aware of for the year ahead.
What you will learn
- Trends and techniques in tender offers, private equity transactions and acquisition financing
- Increasing importance of, and spotlight on, Board process
- Continuing vitality of the poison pill and the “Just Not Now” defense post-Airgas
- Dramatic developments in Delaware law and shareholder litigation
- Impact of shareholder activism and proxy advisory firms
- Insight into the antitrust regulatory landscape
Chicago partner, Jodi Simala will speak on September 23 during a segment entitled “Key Issues in Private Transaction Indemnities.” For more information and to register, please click here.